Carregant...
A placebo-controlled Bayesian dose finding design based on continuous reassessment method with application to stroke research
Traditional dose-finding designs do not require assignment of patients to a control group. Motivated by SHRINC (Safety of Pioglitazone for hematoma resolution in intracerebral hemorrhage), we developed a placebo-controlled dose-finding study to identify the maximum tolerated dose for pioglitazone in...
Guardat en:
| Publicat a: | Contemp Clin Trials Commun |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5650116/ https://ncbi.nlm.nih.gov/pubmed/29062975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2017.05.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|